Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
| Glavni autori: | , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Serija: | Бюллетень сибирской медицины |
| Teme: | |
| Online pristup: | https://bulletin.ssmu.ru/jour/article/view/1618 |